 |
|
|
| |
Perspectives of People With HIV (PWH) 12 Months Following a Switch to Cabotegravir and Rilpivirine Long-Acting (CAB+RPV LA) in an Observational Real-world US Study (BEYOND)
|
| |
| |
AIDS 2024 July 20-26 Numich
William Valenti,1 Dima Dandachi,2 Doug Cunningham,3 Ricky Hsu,4 Kaitlin Nguyen,5 Paula Teichner,5 Ashley Jean-Louis,6 Maria Reynolds,6 David Richardson,6 Cindy Garris5
1Trillium Health, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA; 2Division of Infectious Diseases, Department of Medicine, University of Missouri-Columbia, MO, USA; 3Pueblo Family Physicians, Phoenix, AZ, USA; 4AHF & NYU Langone Health, New York, NY, USA; 5ViiV Healthcare, Durham, NC, USA; 6RTI Health Solutions, Research Triangle Park, NC, USA
|
| |
|
|
|
|
|
